Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Buspirone
1.2.3 Bupropion
1.2.4 Testosterone
1.2.5 Flibanserin
1.2.6 Bremelanotide
1.2.7 Cognitive Behavior Therapy
1.3 Market by Application
1.3.1 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Perspective (2018-2033)
2.2 Hypoactive Sexual Desire Disorder (HSDD) Treatment Growth Trends by Region
2.2.1 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Hypoactive Sexual Desire Disorder (HSDD) Treatment Historic Market Size by Region (2018-2023)
2.2.3 Hypoactive Sexual Desire Disorder (HSDD) Treatment Forecasted Market Size by Region (2024-2033)
2.3 Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Dynamics
2.3.1 Hypoactive Sexual Desire Disorder (HSDD) Treatment Industry Trends
2.3.2 Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Drivers
2.3.3 Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Challenges
2.3.4 Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hypoactive Sexual Desire Disorder (HSDD) Treatment Players by Revenue
3.1.1 Global Top Hypoactive Sexual Desire Disorder (HSDD) Treatment Players by Revenue (2018-2023)
3.1.2 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue
3.4 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Concentration Ratio
3.4.1 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue in 2022
3.5 Hypoactive Sexual Desire Disorder (HSDD) Treatment Key Players Head office and Area Served
3.6 Key Players Hypoactive Sexual Desire Disorder (HSDD) Treatment Product Solution and Service
3.7 Date of Enter into Hypoactive Sexual Desire Disorder (HSDD) Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hypoactive Sexual Desire Disorder (HSDD) Treatment Breakdown Data by Type
4.1 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Historic Market Size by Type (2018-2023)
4.2 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Forecasted Market Size by Type (2024-2033)
5 Hypoactive Sexual Desire Disorder (HSDD) Treatment Breakdown Data by Application
5.1 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Historic Market Size by Application (2018-2023)
5.2 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size (2018-2033)
6.2 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2018-2023)
6.4 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size (2018-2033)
7.2 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2018-2023)
7.4 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size (2018-2033)
8.2 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size (2018-2033)
9.2 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2018-2023)
9.4 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size (2018-2033)
10.2 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AMAG Pharmaceuticals
11.1.1 AMAG Pharmaceuticals Company Detail
11.1.2 AMAG Pharmaceuticals Business Overview
11.1.3 AMAG Pharmaceuticals Hypoactive Sexual Desire Disorder (HSDD) Treatment Introduction
11.1.4 AMAG Pharmaceuticals Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2018-2023)
11.1.5 AMAG Pharmaceuticals Recent Development
11.2 Allergan, Plc.
11.2.1 Allergan, Plc. Company Detail
11.2.2 Allergan, Plc. Business Overview
11.2.3 Allergan, Plc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Introduction
11.2.4 Allergan, Plc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2018-2023)
11.2.5 Allergan, Plc. Recent Development
11.3 Ivix LLX
11.3.1 Ivix LLX Company Detail
11.3.2 Ivix LLX Business Overview
11.3.3 Ivix LLX Hypoactive Sexual Desire Disorder (HSDD) Treatment Introduction
11.3.4 Ivix LLX Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2018-2023)
11.3.5 Ivix LLX Recent Development
11.4 EndoCeutics, Inc.
11.4.1 EndoCeutics, Inc. Company Detail
11.4.2 EndoCeutics, Inc. Business Overview
11.4.3 EndoCeutics, Inc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Introduction
11.4.4 EndoCeutics, Inc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2018-2023)
11.4.5 EndoCeutics, Inc. Recent Development
11.5 Emotional Brain BV
11.5.1 Emotional Brain BV Company Detail
11.5.2 Emotional Brain BV Business Overview
11.5.3 Emotional Brain BV Hypoactive Sexual Desire Disorder (HSDD) Treatment Introduction
11.5.4 Emotional Brain BV Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2018-2023)
11.5.5 Emotional Brain BV Recent Development
11.6 S1 Biopharma, Inc.
11.6.1 S1 Biopharma, Inc. Company Detail
11.6.2 S1 Biopharma, Inc. Business Overview
11.6.3 S1 Biopharma, Inc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Introduction
11.6.4 S1 Biopharma, Inc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2018-2023)
11.6.5 S1 Biopharma, Inc. Recent Development
11.7 Sprout Pharmaceuticals, Inc.
11.7.1 Sprout Pharmaceuticals, Inc. Company Detail
11.7.2 Sprout Pharmaceuticals, Inc. Business Overview
11.7.3 Sprout Pharmaceuticals, Inc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Introduction
11.7.4 Sprout Pharmaceuticals, Inc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2018-2023)
11.7.5 Sprout Pharmaceuticals, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Buspirone
Table 3. Key Players of Bupropion
Table 4. Key Players of Testosterone
Table 5. Key Players of Flibanserin
Table 6. Key Players of Bremelanotide
Table 7. Key Players of Cognitive Behavior Therapy
Table 8. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 10. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 11. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Region (2018-2023)
Table 12. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 13. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Region (2024-2033)
Table 14. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Trends
Table 15. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Drivers
Table 16. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Challenges
Table 17. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Restraints
Table 18. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 19. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Players (2018-2023)
Table 20. Global Top Hypoactive Sexual Desire Disorder (HSDD) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment as of 2022)
Table 21. Ranking of Global Top Hypoactive Sexual Desire Disorder (HSDD) Treatment Companies by Revenue (US$ Million) in 2022
Table 22. Global 5 Largest Players Market Share by Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Hypoactive Sexual Desire Disorder (HSDD) Treatment Product Solution and Service
Table 25. Date of Enter into Hypoactive Sexual Desire Disorder (HSDD) Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 28. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Market Share by Type (2018-2023)
Table 29. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 30. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Market Share by Type (2024-2033)
Table 31. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 32. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Market Share by Application (2018-2023)
Table 33. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 34. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Market Share by Application (2024-2033)
Table 35. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 38. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 39. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 40. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 41. Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 42. Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 43. Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 44. Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 46. Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 47. Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 48. Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 50. AMAG Pharmaceuticals Company Detail
Table 51. AMAG Pharmaceuticals Business Overview
Table 52. AMAG Pharmaceuticals Hypoactive Sexual Desire Disorder (HSDD) Treatment Product
Table 53. AMAG Pharmaceuticals Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2018-2023) & (US$ Million)
Table 54. AMAG Pharmaceuticals Recent Development
Table 55. Allergan, Plc. Company Detail
Table 56. Allergan, Plc. Business Overview
Table 57. Allergan, Plc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Product
Table 58. Allergan, Plc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2018-2023) & (US$ Million)
Table 59. Allergan, Plc. Recent Development
Table 60. Ivix LLX Company Detail
Table 61. Ivix LLX Business Overview
Table 62. Ivix LLX Hypoactive Sexual Desire Disorder (HSDD) Treatment Product
Table 63. Ivix LLX Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2018-2023) & (US$ Million)
Table 64. Ivix LLX Recent Development
Table 65. EndoCeutics, Inc. Company Detail
Table 66. EndoCeutics, Inc. Business Overview
Table 67. EndoCeutics, Inc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Product
Table 68. EndoCeutics, Inc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2018-2023) & (US$ Million)
Table 69. EndoCeutics, Inc. Recent Development
Table 70. Emotional Brain BV Company Detail
Table 71. Emotional Brain BV Business Overview
Table 72. Emotional Brain BV Hypoactive Sexual Desire Disorder (HSDD) Treatment Product
Table 73. Emotional Brain BV Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2018-2023) & (US$ Million)
Table 74. Emotional Brain BV Recent Development
Table 75. S1 Biopharma, Inc. Company Detail
Table 76. S1 Biopharma, Inc. Business Overview
Table 77. S1 Biopharma, Inc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Product
Table 78. S1 Biopharma, Inc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2018-2023) & (US$ Million)
Table 79. S1 Biopharma, Inc. Recent Development
Table 80. Sprout Pharmaceuticals, Inc. Company Detail
Table 81. Sprout Pharmaceuticals, Inc. Business Overview
Table 82. Sprout Pharmaceuticals, Inc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Product
Table 83. Sprout Pharmaceuticals, Inc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2018-2023) & (US$ Million)
Table 84. Sprout Pharmaceuticals, Inc. Recent Development
Table 85. Research Programs/Design for This Report
Table 86. Key Data Information from Secondary Sources
Table 87. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Type: 2022 VS 2033
Figure 3. Buspirone Features
Figure 4. Bupropion Features
Figure 5. Testosterone Features
Figure 6. Flibanserin Features
Figure 7. Bremelanotide Features
Figure 8. Cognitive Behavior Therapy Features
Figure 9. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 10. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Application: 2022 VS 2033
Figure 11. Hospitals Case Studies
Figure 12. Clinic Case Studies
Figure 13. Others Case Studies
Figure 14. Hypoactive Sexual Desire Disorder (HSDD) Treatment Report Years Considered
Figure 15. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 16. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 17. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Region: 2022 VS 2033
Figure 18. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Players in 2022
Figure 19. Global Top Hypoactive Sexual Desire Disorder (HSDD) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue in 2022
Figure 21. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Country (2018-2033)
Figure 23. United States Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Canada Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Country (2018-2033)
Figure 27. Germany Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. France Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. U.K. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Italy Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Russia Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Nordic Countries Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Region (2018-2033)
Figure 35. China Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Japan Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. South Korea Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Southeast Asia Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. India Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Australia Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Country (2018-2033)
Figure 43. Mexico Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Brazil Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Country (2018-2033)
Figure 47. Turkey Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Saudi Arabia Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. AMAG Pharmaceuticals Revenue Growth Rate in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2018-2023)
Figure 50. Allergan, Plc. Revenue Growth Rate in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2018-2023)
Figure 51. Ivix LLX Revenue Growth Rate in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2018-2023)
Figure 52. EndoCeutics, Inc. Revenue Growth Rate in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2018-2023)
Figure 53. Emotional Brain BV Revenue Growth Rate in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2018-2023)
Figure 54. S1 Biopharma, Inc. Revenue Growth Rate in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2018-2023)
Figure 55. Sprout Pharmaceuticals, Inc. Revenue Growth Rate in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2018-2023)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed